Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 214 entries
View as:

Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00896675 Org: User:
Start: 06/30/07 End: 12/31/09 Due: 12/31/10

Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00466505 Org: User:
Start: 05/31/05 End: 11/30/08 Due: 11/30/09

Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00469937 Org: User:
Start: 02/28/06 End: 03/31/09 Due: 03/31/10

Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00336960 Org: User:
Start: 07/31/02 End: 03/31/08 Due: 03/31/09

Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00765245 Org: User:
Start: 10/31/08 End: 11/30/14 Due: 11/30/15

Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00520845 Org: User:
Start: 10/31/07 End: 01/31/14 Due: 01/31/15

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00957736 Org: User:
Start: 11/30/08 End: 12/31/08 Due: 12/31/09

Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03054038 Org: User:
Start: 07/20/17 End: 03/23/22 Due: 03/23/23

Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02412241 Org: User:
Start: 06/30/15 End: 08/31/20 Due: 08/31/21

Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

Phase: N/A Priority: Normal
NCT ID: NCT06482957 Org: User:
Start: 04/01/22 End: 04/30/29 Due: 04/30/30

Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01205685 Org: User:
Start: 05/31/10 End: 07/31/11 Due: 07/31/12

Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01031446 Org: User:
Start: 10/31/09 End: 08/31/17 Due: 08/31/18

Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02672475 Org: User:
Start: 03/31/16 End: 08/31/23 Due: 08/31/24

Hatha Yoga in Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT02923037 Org: User:
Start: 09/01/16 End: 03/31/19 Due: 03/31/20

Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides

Phase: N/A Priority: Normal
NCT ID: NCT02702310 Org: User:
Start: 05/22/16 End: 09/30/26 Due: 09/30/27

Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01707823 Org: User:
Start: 10/31/12 End: 08/31/18 Due: 08/31/19

Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06140407 Org: User:
Start: 02/14/24 End: 05/27/25 Due: 05/27/26

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Phase: N/A Priority: Normal
NCT ID: NCT02831179 Org: User:
Start: 12/31/17 End: 02/29/20 Due: 02/28/21

Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT04506008 Org: User:
Start: 03/02/21 End: 06/30/27 Due: 06/30/28

PCRC-Supported Legacy Intervention in Pediatric Palliative Care

Phase: N/A Priority: Normal
NCT ID: NCT04059393 Org: User:
Start: 07/27/15 End: 06/05/18 Due: 06/05/19

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Phase: N/A Priority: Normal
NCT ID: NCT00897312 Org: User:
Start: 10/31/06 End: 08/31/08 Due: 08/31/09

Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00897117 Org: User:
Start: 05/31/01 End: 05/31/31 Due: 05/31/32

First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade

Phase: N/A Priority: Normal
NCT ID: NCT01215344 Org: User:
Start: 11/30/10 End: 03/31/18 Due: 03/31/19

Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their Parents

Phase: N/A Priority: Normal
NCT ID: NCT03765099 Org: User:
Start: 02/21/19 End: 12/31/22 Due: 12/31/23

Early Detection of Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03181256 Org: User:
Start: 12/14/17 End: 11/30/24 Due: 11/30/25